Literature DB >> 2991089

Faecal mucus degrading glycosidases in ulcerative colitis and Crohn's disease.

J M Rhodes, R Gallimore, E Elias, R N Allan, J F Kennedy.   

Abstract

Because the normal faecal flora includes bacteria which can produce mucus-digesting glycosidases, it follows that increased digestion of colonic mucus by these bacterial enzymes could be important in the pathogenesis of ulcerative colitis. Faecal activities of potential mucus-degrading glycosidases have therefore been assayed in samples from patients with inflammatory bowel disease and normal controls. The enzymes alpha-D-galactosidase, beta-D-galactosidase, beta-NAc-D-glucosaminidase alpha-L-fucosidase and neuraminidase were assayed. Considerable glycosidase activity was present in most faecal samples. Similar activities of all the enzymes assayed were found in faeces from patients with ulcerative colitis, Crohn's disease and normal controls and there was no significant correlation with disease activity. These results imply that relapse of ulcerative colitis is not initiated by increased degradation of colonic mucus by faecal glycosidases but do not exclude a role for bacterial mucus degradation in the pathogenesis of ulcerative colitis.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2991089      PMCID: PMC1432789          DOI: 10.1136/gut.26.8.761

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  7 in total

1.  Cortisone in ulcerative colitis; final report on a therapeutic trial.

Authors:  S C TRUELOVE; L J WITTS
Journal:  Br Med J       Date:  1955-10-29

2.  The early and late results of surgical treatment for Crohn's disease.

Authors:  F T De Dombal; I Burton; J C Goligher
Journal:  Br J Surg       Date:  1971-11       Impact factor: 6.939

3.  Composition of human colonic mucin. Selective alteration in inflammatory bowel disease.

Authors:  D K Podolsky; K J Isselbacher
Journal:  J Clin Invest       Date:  1983-07       Impact factor: 14.808

4.  Mucosal enzymes in human inflammatory bowel disease with reference to neutrophil granulocytes as mediators of tissue injury.

Authors:  S P Kane; A C Vincenti
Journal:  Clin Sci (Lond)       Date:  1979-10       Impact factor: 6.124

5.  Mucin degradation in human colon ecosystems. Evidence for the existence and role of bacterial subpopulations producing glycosidases as extracellular enzymes.

Authors:  L C Hoskins; E T Boulding
Journal:  J Clin Invest       Date:  1981-01       Impact factor: 14.808

6.  Mucin degradation in human colon ecosystems. Fecal population densities of mucin-degrading bacteria estimated by a "most probable number" method.

Authors:  R S Miller; L C Hoskins
Journal:  Gastroenterology       Date:  1981-10       Impact factor: 22.682

7.  Identification of bacterial glycosidases in rat cecal contents.

Authors:  R Prizont; N Konigsberg
Journal:  Dig Dis Sci       Date:  1981-09       Impact factor: 3.199

  7 in total
  17 in total

1.  Fecal beta-D-galactosidase production and Bifidobacteria are decreased in Crohn's disease.

Authors:  C Favier; C Neut; C Mizon; A Cortot; J F Colombel; J Mizon
Journal:  Dig Dis Sci       Date:  1997-04       Impact factor: 3.199

Review 2.  Colonic mucus and mucosal glycoproteins: the key to colitis and cancer?

Authors:  J M Rhodes
Journal:  Gut       Date:  1989-12       Impact factor: 23.059

3.  Altered lectin binding by colonic epithelial glycoconjugates in ulcerative colitis and Crohn's disease.

Authors:  J M Rhodes; R R Black; A Savage
Journal:  Dig Dis Sci       Date:  1988-11       Impact factor: 3.199

4.  Histochemical demonstration of desialation and desulphation of normal and inflammatory bowel disease rectal mucus by faecal extracts.

Authors:  J M Rhodes; R R Black; R Gallimore; A Savage
Journal:  Gut       Date:  1985-12       Impact factor: 23.059

5.  High-fat diet alters the oligosaccharide chains of colon mucins in mice.

Authors:  Maria Mastrodonato; Donatella Mentino; Piero Portincasa; Giuseppe Calamita; Giuseppa Esterina Liquori; Domenico Ferri
Journal:  Histochem Cell Biol       Date:  2014-04-26       Impact factor: 4.304

6.  In vitro evaluation of dexamethasone-beta-D-glucuronide for colon-specific drug delivery.

Authors:  B Haeberlin; W Rubas; H W Nolen; D R Friend
Journal:  Pharm Res       Date:  1993-11       Impact factor: 4.200

7.  Lancemaside A ameliorates colitis by inhibiting NF-kappaB activation in TNBS-induced colitis mice.

Authors:  Eun-Ha Joh; In-Ah Lee; Sang-Jun Han; Sunju Chae; Dong-Hyun Kim
Journal:  Int J Colorectal Dis       Date:  2009-12-03       Impact factor: 2.571

8.  Effect of nicotine on rectal mucus and mucosal eicosanoids.

Authors:  F J Zijlstra; E D Srivastava; M Rhodes; A P van Dijk; F Fogg; H J Samson; M Copeman; M A Russell; C Feyerabend; G T Williams
Journal:  Gut       Date:  1994-02       Impact factor: 23.059

9.  Lactobacillus suntoryeus inhibits pro-inflammatory cytokine expression and TLR-4-linked NF-kappaB activation in experimental colitis.

Authors:  Jung-Hee Lee; Bomi Lee; Hye-Sung Lee; Eun-Ah Bae; Hoyong Lee; Young-Tae Ahn; Kwang-Sei Lim; Chul-Sung Huh; Dong-Hyun Kim
Journal:  Int J Colorectal Dis       Date:  2008-12-03       Impact factor: 2.571

10.  The roles of enteric bacterial sialidase, sialate O-acetyl esterase and glycosulfatase in the degradation of human colonic mucin.

Authors:  A P Corfield; S A Wagner; L J O'Donnell; P Durdey; R A Mountford; J R Clamp
Journal:  Glycoconj J       Date:  1993-02       Impact factor: 2.916

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.